Genetic Inactivation of RelA/p65 Sensitizes Adult Mouse Hepatocytes to TNF-induced Apoptosis In Vivo and In Vitro

Gastroenterology

Volumn 132, Issue 7, 2007, Pages 2489-2503

  Geisler, Fabian ^a   Algül, Hana ^a   Paxian, Stephan ^b   Schmid, Roland M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CASPASE 3; CASPASE 8; FLICE INHIBITORY PROTEIN; I KAPPA B KINASE BETA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE DELETION; GENE DISRUPTION; GENE INACTIVATION; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 34250021317     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.03.033     Document Type: Article

References (52)

1. Wajant H., Pfizenmaier K., and Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 10 (2003) 45-65
2. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
3. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morbach S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., and Schutze S. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004) 415-428
4. Schneider-Brachert W., Tchikov V., Merkel O., Jakob M., Hallas C., Kruse M.L., Groitl P., Lehn A., Hildt E., Held-Feindt J., Dobner T., Kabelitz D., Kronke M., and Schutze S. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J Clin Invest 116 (2006) 2901-2913
5. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481-490
6. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376 (1995) 167-170
7. Rosenfeld M.E., Prichard L., Shiojiri N., and Fausto N. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 156 (2000) 997-1007
8. Doi T.S., Marino M.W., Takahashi T., Yoshida T., Sakakura T., Old L.J., and Obata Y. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A 96 (1999) 2994-2999
9. Karin M., and Lin A. NF-κB at the crossroads of life and death. Nat Immunol 3 (2002) 221-227
10. Burstein E., and Duckett C.S. Dying for NF-κB?. Control of cell death by transcriptional regulation of the apoptotic machinery. Curr Opin Cell Biol 15 (2003) 732-737
11. Cory S., and Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2 (2002) 647-656
12. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., and Karin M. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor-κB activation and prevention of apoptosis. J Exp Med 189 (1999) 1839-1845
13. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., and Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93 (1998) 1231-1240
14. Hu Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R., and Karin M. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284 (1999) 316-320
15. Li Q., Van Antwerp D., Mercurio F., Lee K.F., and Verma I.M. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284 (1999) 321-325
16. Tanaka M., Fuentes M.E., Yamaguchi K., Durnin M.H., Dalrymple S.A., Hardy K.L., and Goeddel D.V. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10 (1999) 421-429
17. Rudolph D., Yeh W.C., Wakeham A., Rudolph B., Nallainathan D., Potter J., Elia A.J., and Mak T.W. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev 14 (2000) 854-862
18. Nagaki M., Naiki T., Brenner D.A., Osawa Y., Imose M., Hayashi H., Banno Y., Nakashima S., and Moriwaki H. Tumor necrosis factor α prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-κB. Hepatology 32 (2000) 1272-1279
19. Chaisson M.L., Brooling J.T., Ladiges W., Tsai S., and Fausto N. Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 110 (2002) 193-202
20. Lavon I., Goldberg I., Amit S., Landsman L., Jung S., Tsuberi B.Z., Barshack I., Kopolovic J., Galun E., Bujard H., and Ben-Neriah Y. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nat Med 6 (2000) 573-577
21. Schwabe R.F., Uchinami H., Qian T., Bennett B.L., Lemasters J.J., and Brenner D.A. Differential requirement for c-Jun NH2-terminal kinase in TNFα- and Fas-mediated apoptosis in hepatocytes. FASEB J 18 (2004) 720-722
22. Maeda S., Chang L., Li Z.W., Luo J.L., Leffert H., and Karin M. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19 (2003) 725-737
23. Luedde T., Assmus U., Wustefeld T., Meyer zu Vilsendorf A., Roskams T., Schmidt-Supprian M., Rajewsky K., Brenner D.A., Manns M.P., Pasparakis M., and Trautwein C. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 115 (2005) 849-859
24. Kuhn R., Schwenk F., Aguet M., and Rajewsky K. Inducible gene targeting in mice. Science 269 (1995) 1427-1429
25. Postic C., and Magnuson M.A. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26 (2000) 149-150
26. Geisler F., Algul H., Riemann M., and Schmid R.M. Questioning current concepts in acute pancreatitis: endotoxin contamination of porcine pancreatic elastase is responsible for experimental pancreatitis-associated distant organ failure. J Immunol 174 (2005) 6431-6439
27. Postic C., Shiota M., Niswender K.D., Jetton T.L., Chen Y., Moates J.M., Shelton K.D., Lindner J., Cherrington A.D., and Magnuson M.A. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274 (1999) 305-315
28. Grell M., Douni E., Wajant H., Lohden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., and Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83 (1995) 793-802
29. Schwandner R., Wiegmann K., Bernardo K., Kreder D., and Kronke M. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J Biol Chem 273 (1998) 5916-5922
30. Osawa Y., Banno Y., Nagaki M., Nozawa Y., Moriwaki H., and Nakashima S. Caspase activation during hepatocyte apoptosis induced by tumor necrosis factor-α in galactosamine-sensitized mice. Liver 21 (2001) 309-319
31. Neumeyer J., Hallas C., Merkel O., Winoto-Morbach S., Jakob M., Thon L., Adam D., Schneider-Brachert W., and Schutze S. TNF-receptor I defective in internalization allows for cell death through activation of neutral sphingomyelinase. Exp Cell Res 312 (2006) 2142-2153
32. Liu H., Lo C.R., and Czaja M.J. NF-κB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35 (2002) 772-778
33. Chang L., Kamata H., Solinas G., Luo J.L., Maeda S., Venuprasad K., Liu Y.C., and Karin M. The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIP(L) turnover. Cell 124 (2006) 601-613
34. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98 (2001) 13681-13686
35. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., Piao J.H., Yagita H., Okumura K., Doi T., and Nakano H. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22 (2003) 3898-3909
36. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
37. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A., Mirtsos C., Suzuki N., Bonnard M., Goeddel D.V., and Mak T.W. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12 (2000) 633-642
38. Haefner B. NF-κB: arresting a major culprit in cancer. Drug Discov Today 7 (2002) 653-663
39. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 3 (2004) 17-26
40. Varfolomeev E.E., and Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie?. Cell 116 (2004) 491-497
41. Liu Z.G. Adding facets to TNF signaling. The JNK angle. Mol Cell 12 (2003) 795-796
42. De Smaele E., Zazzeroni F., Papa S., Nguyen D.U., Jin R., Jones J., Cong R., and Franzoso G. Induction of gadd45β by NF-κB down-regulates pro-apoptotic JNK signalling. Nature 414 (2001) 308-313
43. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., and Lin A. Inhibition of JNK activation through NF-κB target genes. Nature 414 (2001) 313-317
44. Lee E.G., Boone D.L., Chai S., Libby S.L., Chien M., Lodolce J.P., and Ma A. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289 (2000) 2350-2354
45. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., Jayawardena S., De Smaele E., Cong R., Beaumont C., Torti F.M., Torti S.V., and Franzoso G. Ferritin heavy chain up-regulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119 (2004) 529-542
46. Streetz K., Fregien B., Plumpe J., Korber K., Kubicka S., Sass G., Bischoff S.C., Manns M.P., Tiegs G., and Trautwein C. Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure. J Immunol 167 (2001) 514-523
47. Wang Y., Singh R., Lefkowitch J.H., Rigoli R.M., and Czaja M.J. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem 281 (2006) 15258-15267
48. Micheau O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003) 181-190
49. Scaffidi C., Schmitz I., Krammer P.H., and Peter M.E. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274 (1999) 1541-1548
50. Kataoka T., and Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-κB signaling pathway. Mol Cell Biol 24 (2004) 2627-2636
51. Kreuz S., Siegmund D., Scheurich P., and Wajant H. NF-κB inducers up-regulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21 (2001) 3964-3973
52. Poukkula M., Kaunisto A., Hietakangas V., Denessiouk K., Katajamaki T., Johnson M.S., Sistonen L., and Eriksson J.E. Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail. J Biol Chem 280 (2005) 27345-27355